SARS-CoV-2 vaccination responses in patients with immune diseases
2021
Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
The authors analysed the vaccination responses in 84 patients with immune-mediated inflammatory diseases (IMIDs) and 182 healthy adults (controls) vaccinated with the BNT162b2 mRNA SARS-CoV-2 vaccine (BioNTech/Pfizer). 99.5% of controls but only 90.5% of patients with IMID developed neutralising antibody activity. Furthermore, the overall immune responses were delayed in patients with IMID. A lower incidence of side effects was also detected in these patients.
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
Georg Schett
Added on: 05-12-2021
[1] https://ard.bmj.com/content/early/2021/05/05/annrheumdis-2021-220461[2] https://www.n-tv.de/wissen/Impfantwort-bei-Autoimmunkranken-gestoert-article22550735.html
